(Il Sole 24 Ore Radiocor) - Milano, 16 feb - In London trade, shares of the biotech group SkinBioTherapeutics slumped 48.69% to 6.35 pence after the company drastically revised its 2025 results and 2026 guidance following the discovery of financial "inaccuracies" during an investigation into its former CEO.

In Milan, Sanlorenzo shares jumped 4.19% to 34.80 euros as investors cheered full year results that beat expectations and a target price upgrade from brokerage Akros.

In Frankfurt, Commerzbank shares added 2.11% to 32.91 euros, as financial stocks rebounded from last week's AI related.

concerns.

(RADIOCOR) 16-02-26 11:55:30 (0217) 5 NNNN